Navigation Links
Opportunities to Invest in Puerto Rico as Global Center for Biotechnology
Date:2/12/2008

25% of world's biological manufacturing capacity is in Puerto Rico

MEXICO CITY, Feb. 12 /PRNewswire/ -- A quarter of the world's biotechnology manufacturing capacity is located in Puerto Rico, making it one of the largest concentrations in the world.

Over the past four years, more than $4 billion has been invested in biotechnology in Puerto Rico by such giants as Eli Lilly, Amgen, Abbot, Ortho Biologics, BD Biosciences and Bristol Myers Squibb. The Puerto Rico Conference, Investment for Growth, organized by the Puerto Rico Chamber of Commerce, will feature a panel on The Biotech Island. Panelists will discuss the factors that are making the island so attractive for this type of investment.

The panelists will include Emilio Rivera, Vice-President of Manufacturing Operations of Amgen Puerto Rico, a company that has expanded twice in the past six years and invested $2 billion; Samuel Malone, President of Eli Lilly & Company Puerto Rico; and Edgardo Fabregas, Vice-President of Pharmaceutical Manufacturing at Johnson & Johnson and the person responsible for the corporation's manufacturing operation in Puerto Rico, Asia and Europe. Eli Lilly built the world's largest modular biotechnology facility in Puerto Rico, where it produces Humalog, recombinant human insulin for the treatment of diabetes.

The Puerto Rico Conference, to be held February 19 & 20 at the Hotel Ritz Carlton in San Juan, is aimed at presenting investment opportunities in Puerto Rico. "We organized the conference around the many areas of interest to investors in which Puerto Rico offers unique opportunities," said Francisco Rodriguez-Castro, organizer and Chair of the Conference. "The response so far has been very positive. We are getting a lot of interest from investors in the U.S. and Puerto Rico," he said. "Our mission is to showcase Puerto Rico's business sector and its many possibilities as we strengthen it with this type of event," said Jose Julian Alvarez, Chairman of the Board of the Puerto Rico Chamber of Commerce.

The conference will also focus on a general presentation of Puerto Rico's economy, growing opportunities in the health sector, and banking, financing vehicles available, real estate investment trusts as a new investment opportunity in Puerto Rico, and developments in tourism, retail and communications.

The Puerto Rico Chamber of Commerce is a non-profit organization established in 1913. It is the most inclusive multi-sector organization on the island and it has traditionally been the voice that represents the private sector. Each year, multiple events, such as this one, are organized to promote and facilitate opportunities that will support the socioeconomic development of Puerto Rico. To make reservations and/or obtain more information, log on to http://www.camarapr.org; or call 1-787-721-6060 extension 2209 from Monday to Friday during work hours (8:00a.m. to 5:00p.m.).

Contact:

Nancy Robles

Puerto Rico Chamber of Commerce

(787) 721-6060 ext. 2209

(787) 474-6092 direct.

Email: nrobles@camarapr.net


'/>"/>
SOURCE Puerto Rico Chamber of Commerce
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. European blood researchers receive award to pursue research opportunities in US
2. Healthcare Tech and the World: Podcast Examines The Challenges & Opportunities for Change in the Healthcare Industry
3. Perdue AgriBusiness Announces Low Linolenic Soybean Contracting Opportunities with DuPont Business Pioneer Hi-Bred
4. Workplace opportunities and stresses are both increasing
5. Lilly Showcases Pipeline Opportunities to Wall Street, Sets 2008 Financial Guidance and Outlines Transformation Strategy
6. Holidays Can Present Drinking Opportunities for Teens
7. Biotech Company Builder Papadopoulos Says Investment in Innovation Needed to Advance Drug Pipeline at Massachusetts Biotechnology Councils Ninth Annual MASS Opportunities Investment Conference
8. Alcohol and cancer -- recent research and prevention opportunities
9. In Celebration of Breast Cancer Awareness Month, Susan G. Komen for the Cure San Diego Announces Opportunities for San Diegans to Get Involved in the Fight Against Breast Cancer
10. Investor Insight Initiates Analyst Coverage on Crdentia
11. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... ... February 24, 2017 , ... With millions of Americans ... important that we all are aware of our options and are empowered with ... announce the launch of its newest edition of "Vision and Hearing" in USA ...
(Date:2/24/2017)... Viejo, CA (PRWEB) , ... February 24, 2017 , ... ... Final Cut Pro X . Users have total control over position, rotation, distortion, ... and more all within Final Cut Pro X. , With ProGlass Prism users are ...
(Date:2/24/2017)... ... February 24, 2017 , ... The International Association of Eating Disorders Professionals (iaedp) ... You See” body image mannequin art competition. Selected from 15 submissions from around the ... revealed at the 31st annual iaedp Symposium, March 22 – 26 in Las Vegas. ...
(Date:2/24/2017)... , ... February 24, 2017 , ... ... services, which specializes in thought leadership , media relations, social media, content ... services that will be powered through Act-On, an intuitive marketing automation platform. , ...
(Date:2/23/2017)... ... February 23, 2017 , ... Thinksport, the most ... Jensie Gran Fondo of Marin. For the second year in a row, cyclists ... sunscreen. , “We are thrilled to provide our safe, non-toxic sunscreen to over ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 23, 2017  The particle counters market is ... from USD 275.9 million in 2016, at a ... report: http://www.reportlinker.com/p04718602-summary/view-report.html The growing ... R&D, and growth in manufacturing industries in emerging ... for particle counters. On the other hand, technical ...
(Date:2/24/2017)... Feb. 24, 2017  Xynomic Pharmaceuticals, Inc., an oncology ... it has acquired exclusive worldwide rights to develop, ... HDAC inhibitor targeting hematological and solid tumors. ... 1 and 2 clinical trials of Abexinostat in ... have already been completed, demonstrating that Abexinostat is ...
(Date:2/23/2017)... , Feb. 23, 2017 Visiomed, ... and services since 1997, is changing the landscape ... technology providing patients with pro-active, custom-made solutions. Recognizing ... for instant and affordable healthcare without walls, Visiomed ... high-level devices developed with healthcare professionals that is ...
Breaking Medicine Technology: